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Objectives: To summarise the evidence-base of psychological interventions for women with 
metastatic breast cancer (MBC), by mode of delivery (group, individual, or low-intensity 
interventions). To synthesise data regarding core intervention-elements (e.g., intervention 
duration) and context factors (trial setting, uptake and adherence, demographic 
characteristics).  
Methods: Four databases were searched (inception – May 2016): MEDLINE (OvidSP), 
PsycINFO (OvidSP), CINAHL (EBSCO), and SCOPUS; reference lists were examined for 
additional publications. Grey literature was excluded. Outcome data were extracted for 
survival, distress, quality of life, coping, sleep, fatigue, and/or pain, and summarised through 
narrative synthesis.  
Results: Fifteen randomised clinical trials (RCTs), reported across 23 articles, met inclusion 
criteria: seven group, four individual, and four low-intensity interventions. Overall, 
interventions improved distress (8/13 RCTs); coping (4/5 RCTs); and pain (4/5 RCTs). No 
evidence of survival benefit was found. For remaining outcomes, evidence was either 
insufficient, or too mixed to draw conclusions. Group programs had the strongest evidence-
base for efficacy; individual and low-intensity therapy had insufficient evidence to form 
conclusions. Group interventions had longest intervention durations and lowest uptake and 
adherence; low-intensity interventions had shortest durations and highest uptake and 
adherence. Disparities in uptake, adherence and reach were evident, with the demographic 
profile of participants polarised to young, Caucasian, English-speaking, partnered women.  
Conclusions: There remains a paucity of psychological interventions for women with MBC. 
Those that exist have an inconsistent evidence-base across the range of patient-reported 
outcomes. Further research is needed to evaluate accessible delivery formats that ensure 
efficacy as well as uptake.  
Abstract word count: 245 
Keywords: cancer, oncology, metastatic breast cancer, psychological interventions, 
systematic review, treatment-modality  
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Metastatic breast cancer (MBC) is defined as cancer that has spread from the breast to more 
distant parts of the body, most commonly the bones, lungs, liver, and brain [1]. Despite the 
advent of new systemic therapies, the median survival remains approximately two to three 
years [2], although some women experience extended survival periods of over 10 years. 
A diagnosis of advanced breast cancer brings significant adjustment challenges for women, 
as they face a future of physical symptoms, functional limitations, and existential concerns 
about their ultimate mortality. Clinically elevated distress and impaired health-related quality 
of life (HRQOL) occur in 35-43% [3] of women following diagnosis of MBC. Given that 
psychological factors, particularly depression, have been implicated in reduced survival time 
[4], increased severity of symptoms[5], and reduced treatment adherence [6], psychosocial 
interventions for this population are warranted. 
However, contrasting to the 28 randomised controlled trials (RCTs) of psychological 
interventions for 3940 participants with early-stage breast cancer [7], the Cochrane 
Collaboration found only 10 RCTs had been specifically conducted for 1378 women with 
MBC [8]. This MBC Cochrane Review, a meta-analysis published in 2013, included papers 
published between 1989 and 2010, with seven of the 10 included RCTs evaluating a group-
therapy program of either a supportive-expressive (n=4), or cognitive behavioural (n=3) 
framework [8]. The remaining three studies trialled individual face-to-face therapies, and did 
not utilise either of these therapeutic frameworks. Overall, the Cochrane Review found a 
short-term psychological benefit of MBC-interventions for improving pain and psychological 
outcomes (distress, helplessness/hopelessness, social functioning, cancer-related distress, 
emotional control), and a modest survival benefit at one year which was not sustained at five 
years [8].  
Since publication of the Cochrane Review, there has been a surge of interest in the provision 
of online self-directed psychological interventions targeting illness-related distress [9-18]. 
Furthermore, recent survey data indicates that psychosocial needs remain the key concern of 
women with MBC, with self-care strategies being listed as the most-preferred or second-
preferred option for distress management [19]. These web-based and self-care strategies form 
part of an emerging modality for receiving psychological interventions, termed ‘low-
intensity’ [20]. The primary purpose of low intensity interventions is to increase access to 
evidence-based psychological therapies, using the minimum level of intervention necessary 
to create maximum gain, and delivering content in a variety of flexible forms, including 
email, smart-devices, telephone, print-based resources, and internet [20]. While definitions 
vary, the key attributes of low-intensity interventions are that they are more accessible; use 
fewer formal healthcare professionals’ resources compared to conventional therapies; and 
may use non-specialist practitioners to deliver the programs [20, 21]. In contrast, group and 
individual psychotherapeutic interventions are high-intensity, defined as therapist-
administered programs, delivered in-person by health professionals with specialist training 
[8], and can be of either brief (less than 6 hours) or extensive duration [21]. Considering the 
research and patient preference developments relating to low-intensity interventions, 
particularly web-based psychological therapy, it is timely to investigate whether they have 
penetrated the MBC-literature, and to update the evidence in light of any new, or previously 
missed, trials that have been published.  
Given the variety of formats now available for disseminating psychological interventions, it 
is important to evaluate how the core elements of an intervention (modality of delivery, and 
their differing treatment durations) impact on outcomes. While the prior Cochrane Review 
summarised the number of group and individual interventions included, they did not compare 
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outcomes by delivery modality [8]. Furthermore, it is also becoming increasingly recognised 
that research data must be considered within the context they were obtained. That is, to 
identify (a) in what setting, (b) under what conditions, and (c) for which specific section of 
the population the evidence was derived, in order to then understand the implications for 
subsequent implementation. These context and intervention-elements data have not 
previously been summarised, but have important implications for reach and uptake.  
This current review therefore aimed to (a) update efficacy findings from a previous Cochrane 
Review of psychological interventions for women with MBC, to include any missed RCTs, 
or RCTs published in the subsequent 5 years, (b) summarise outcomes  by treatment-
modality, and (c) synthesise the following intervention-duration and trial context data: rates 
of uptake (defined as the number of consenting participants as a proportion of approached 
eligible individuals, e.g. [22]), adherence (the amount of an intervention an individual 
engages with or completes [23]), the geographic and medical settings of trials conducted, and 
the demographic profile of included participants.  
Method 
Methodological Framework 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
statement was used [24] and a review protocol was developed (Online Appendix 1).  
Data Sources 
Two methods of identifying primary studies were utilised. First, one author (LB) conducted 
four electronic bibliographic database searches (from each database’s inception to May 
2016): MEDLINE, PsycInfo, CINAHL and SCOPUS. A list of keywords and MeSH terms 
were generated to identify studies, falling within three key search strategies (for full details, 
see online supplemental materials Appendix 1 - Review protocol):  
(i) Terms related to metastatic breast cancer: ‘metasta*’, ‘secondary’, ‘advanced’, 
‘breast cancer’;  
(ii) Terms related to psychological intervention: ‘psycho*’, ‘intervention’, 
‘psychotherapy’, ‘group support*’, ‘self-help’ ‘internet*’, ‘tele-counsel*’;  
(iii) Terms related to outcomes: ‘survival’; ‘quality of life’, ‘psychosocial’.  
This initial search identified 1151 citations (740 after de-duplication). The reference lists of 
the included primary studies and previous systematic reviews were then screened to identify 
further articles. The full electronic search strategy used for one database (PsycINFO) is 
included in Online Appendix 2. Figure 1 (see online supplemental materials) summarises the 
search and retrieval process utilised. 
Study Selection 
The title and abstract of each citation were examined against the following pre-specified 
inclusion and exclusion criteria:  
1. The article was published, or in-press, in a peer-reviewed journal between database 
inception and 25th May 2016. Grey literature was excluded.  
2. The intervention targeted adult women with a diagnosis of metastatic or recurrent 
breast cancer.  
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3. Studies including women with MBC as part of a larger sample of patients with other 
cancer types or stages were eligible for inclusion if data could be extracted specific to 
women with MBC. There were no restrictions on the minimum MBC-sample size 
required.  
4. The intervention was psychotherapeutic in nature (i.e., provided psychological 
strategies, of any therapeutic framework, to manage illness-related challenges). 
Interventions providing information/education without a therapeutic component were 
excluded.  
5. Survival, distress, coping, quality of life, or somatic symptoms was an outcome.  
6. The study was a randomised controlled trial (RCT), quasi-randomised trial, or 
feasibility RCT.  
7. The article was published in English. 
Initial assessment of eligibility was performed by EK based on titles and abstracts. Database 
searches were then replicated by one other author (LB or BK). There was 97.6% agreement 
(kappa = 0.767) on the selected review articles. Disagreement in selection was resolved 
through discussion between authors. Full-texts of citations meeting initial inclusion criteria 
were obtained. All full-texts were independently examined by two authors (LB and EK) to 
confirm inclusion/exclusion, with 100% agreement obtained.  
Data Extraction 
Data were extracted independently by two members of the authorship group using a 
standardised coding sheet, based on the Cochrane library’s recommendations for data 
extraction [25]. Where discrepancies occurred in the data extracted by the initial reviewing 
authors, a third author (LB/EK) reviewed the data and consensus was reached through 
discussion. Interventions were coded as either ‘Group’, ‘Individual’, or ‘Low-Intensity’ 
during extraction and synthesis. Group and individual interventions were stated as such in 
papers and were delivered in person. To be classified as ‘Low-Intensity’, interventions had to 
meet four criteria drawn from definitions of low-intensity therapies [20, 21]: (a) administered 
in a non-face-to-face setting; (b) delivered by non-mental health practitioners; (c) be more 
accessible; and (d) be briefer for the practitioner compared to therapist-delivered treatments.. 
Quality Assessment 
The quality of each paper was assessed by two authors independently: the research design 
quality was assessed using the five criteria for empirically supported psychotherapies [26]; 
and the quality of reporting was secondly assessed at the study level using six criteria from 
the Cochrane Collaboration’s ‘risk of bias’ tool [25].  
Data Synthesis 
A narrative synthesis of results was utilised due to the substantial heterogeneity in study 
design, population, type of intervention, outcomes, and timing of assessments. The first 
author synthesised results, with findings verified by the authorship group. 
Results 
Flow of studies through the review 
From the initial pool of 740 screened titles and abstracts, 47 citations met inclusion criteria 
for full review. Two potential studies were identified from reference lists of the initial full-
texts screen. Of these 49 total citations, 26 were subsequently excluded during full-text 
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analysis, because: MBC-specific patient data could not be extracted from larger samples of 
mixed cancer types (n=14); the study was not an RCT (n=6); the intervention was not 
psychotherapeutic (n=4); or the publication did not evaluate efficacy (n=2). Therefore 23 
articles (from 15 RCTs) were included [27-49]. Five RCTs not summarised by the previous 
Cochrane review were identified and included in this review; four were published prior to the 
previous Cochrane Review update [28, 37, 41, 48]. Of note, only one new RCT was 
published in the past 5 years [43].  
Overview of included studies 
Table A (see online supplemental materials) summarises the characteristics of the 15 RCTs 
reported across 23 articles, with studies listed by treatment-delivery modality. A total of 1638 
women participated in the RCTs; seven interventions (50%) were delivered in a group format 
[31-33, 38, 40, 41, 45]; four in individual therapy [27, 28, 44, 48]; and four as ‘low-intensity’ 
(telephone counselling, n=2; expressive writing, n=2) [37, 39, 42, 43]. None of the included 
studies trialled online/web-based therapy. Most (n=13) interventions fell into five therapeutic 
frameworks: (i) Supportive Expressive Group Therapy (SEGT; n=4)[31, 38, 40, 45]; (ii) 
Cognitive Behaviour Therapy (CBT; n=5) [28, 33, 37, 44, 48]; (iii) SEGT/CBT combined 
(n=1) [32]; (iv) Expressive Writing (n=2) [42, 43]; (v) Hypnosis [41]; with the remaining two 
RCTs trialling telephone counselling [39], and a nurse-lead counselling program [27]. 
Program duration ranged from 80 minutes (expressive writing), to 78 hours (SEGT); 
treatment providers ranged from none (expressive writing) to two highly skilled co-therapists 
(CBT, SEGT); and the setting was predominantly urban hospitals or clinics (n=11/15).  
 
Methodological quality 
Table B (see online supplemental materials) summarises the methodological quality of the 
included RCTs. Overall, the methodological quality was moderate. While no RCT met all 11 
combined criteria, eight (53%) RCTs met at least eight of the 11 combined criteria [31-33, 
38-40, 43, 48]. The majority of these higher quality studies were group-delivered [31-33, 38, 
40]; one individual therapy [48], and two low-intensity [39, 43] studies met this quality 
criteria threshold.  
Looking at the criteria separately, six trials (40%) met all the research design criteria [31, 33, 
38-40, 43].  All trials utilised acceptable control conditions: eight RCTs utilised less 
methodologically rigorous comparators (usual care, n=5 [27, 28, 33, 39, 45]; waitlist control, 
n=3 [41, 44, 48]); while seven had stronger control conditions (attention-control, n=5 [31, 38, 
40, 42, 43]; active-treatment control, n=2 [32, 37]). Most studies (n=11) had sample sizes 
larger than 25 participants per group, however only six trials reported their power 
calculations and were sufficiently powered to detect moderate effects. All except one study 
[44] specified inclusion criteria, and only two studies did not clearly report or did not use 
reliable/well-validated measures [37, 44].  
No RCT met all 6 reporting criteria for risk of bias [25]. Twelve studies (80%) gave 
sufficient information about how the allocation sequence was generated, and nine of these 
gave sufficient information about whether allocation was adequately concealed. Only two 
studies specifically met the criteria for blinded assessment by research personnel (no trial 
reported on participant blinding) [43, 48]. Strategies to manage incomplete outcome data 
were reported in seven (47%) RCTs, while nine trials were free of selective reporting of 
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outcomes. Finally, only five RCTs (33%) were clearly free of other bias, with the majority of 
studies being either unclear in their reporting (n=7) or not meeting this criterion (n=3).  
Trial Outcomes 
There was marked heterogeneity in outcomes, measures utilised, and timing of assessments in 
included trials. Only seven RCTs specified a primary outcome (group: n=4, individual: n=1, 
low-intensity: n=2); specifically, survival (n=3); mood disturbance (n=2); quality of life 
(n=1), and symptom severity response time (n=1). In order to increase clarity of findings, this 
review consolidated outcomes into the following domains: (a) survival; (b) distress 
(incorporating depression, anxiety, stress, cancer-related distress, intrusive thoughts); (c) 
coping (incorporating mental adjustment domains such as helplessness, denial, repression); 
(d) quality of life; and the commonly reported cancer symptoms of (e) pain (intensity, 
suffering, sensation, duration, perceived ability to control); (f) fatigue; and (g) sleeping 
difficulties. Given the marked heterogeneity of number and timing of assessments, and the 
analyses conducted, comparing the short versus long term benefits of interventions was not 
possible. This review therefore adopted an inclusive criterion coding an intervention as a 
positive trial if it yielded a favourable impact on an outcome for at least one of the follow-up 
assessments. Table 1 summarises the evidence-base per outcome domain, by treatment-
delivery modality for the included trials, with an overall (pooled) summary of the evidence-
base. This review did not synthesise outcomes analysed in fewer than two trials: these 
included social support, self-efficacy, and self-esteem; these outcomes were instead reported 
per individual study in Table A (see online supplemental materials).  
Survival 
Six RCTs investigated survival as an outcome, all delivered as group programs [32, 34, 38, 
40, 46, 47]; only the first published study [47] found a statistically significant survival benefit 
resulting from group participation. Of note, none of the three studies that were specifically 
powered for survival as a primary outcome obtained significant effects [32, 38, 40]. 
Distress 
Pooling across intervention types, ‘distress’ was the most frequently assessed outcome, 
investigated in 13 trials [28, 31-33, 37-43, 45, 48]: eight RCTs demonstrated efficacy for at 
least one distress outcome [31, 33, 37, 38, 40, 41, 45, 48], of which seven  tested established 
therapeutic frameworks (i.e., SEGT, CBT).  Breaking results down by treatment modality, 
Table 1 demonstrates that six of the seven group-therapy trials examining distress were 
positive (86%), including the single trial that specified distress as a primary outcome [31]; 
one of the two individual therapy trials was positive (50%), while one low-intensity trial 
obtained significant effects (25%), with the remaining three low-intensity RCTs, including 
one that specified distress as a primary outcome [39], failing to find effects. Therefore, while 
the evidence-base for psychological therapy (pooled across treatment modalities) for distress 
was supported, only group-delivered programs consistently demonstrated positive results. 
Coping 
Five trials examined coping domains as an outcome [31, 32, 40, 44, 45]. Four were group-
delivered; and all four obtained positive effects, therefore reaching criteria for being 
considered empirically supported. However, findings were significant only for certain 
domains; helplessness/hopelessness [32, 40], restraint [31], and a ‘maladaptive coping’ sub-
scale [45], but not for other commonly-reported coping styles including denial, defensive-
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repressive coping, anxious preoccupation, cognitive avoidance, fatalism or fighting spirit [31, 
32, 40, 45]. The fifth trial was for individually-administered therapy [44], where coping was 
not statistically significantly impacted by the intervention. No trial to date has examined the 
impact of low-intensity interventions on coping outcomes.  
Quality of Life 
Six RCTs evaluated quality of life: three were group programs [32, 38, 40]; three were 
individual therapy [27, 44, 48]. Only one group-therapy trial reported statistically significant 
effects [40], in the specific QOL domain of social functioning, with the remaining five RCTs 
failing to find an effect, including one that specified QOL as a primary outcome [44]. 
Psychological interventions for quality of life are therefore currently unsupported, both 
within delivery-modalities and overall. 
Pain 
Pain was evaluated in five RCTs: three group trials [29, 30, 49]; one individual [28], and one 
low-intensity [37]. When pooling across the RCTs, four of the five psychological 
interventions trialled had an impact on pain intensity, sensation, suffering or perceived 
control over pain [28-30, 49]. Only the low-intensity intervention did not have an impact on 
pain [37]. Overall the use of psychological interventions, delivered in a face-to-face format 
(either group or individually), is currently supported; however the lack of trials for individual 
and low-intensity modalities preclude definitive recommendations being formed.  
Fatigue 
Fatigue was evaluated in five RCTs: two group interventions [29, 45]; one individual therapy 
[48]; and two low-intensity interventions [37, 43]. Only one of the five trials, a group 
intervention [45], demonstrated efficacy. Based on the current evidence, there is insufficient 
data to draw conclusions regarding the use of psychological intervention to treat cancer-
related fatigue in MBC.  
Sleeping Difficulties 
Four trials examined sleep: one individual intervention [48], and three low-intensity [37, 42, 
43]. Two of the three low-intensity RCTs found evidence of benefit [37, 42]; however, for 
one of these trials, the benefits only applied to those ‘recently’ diagnosed with MBC, defined 
as within the past 20 months [42]. The remaining two trials failed to obtain significant results 
for improving sleep. The impact of psychological interventions, both overall or by treatment-
modality, on sleep-related difficulties therefore remains unclear based on the limited data 
currently available.  
Trial Context 
Table 2 summarises intervention duration and contextual factors associated with trial 
participation. As can be seen, the overall number of participants and average sample size per 
trial differed between treatment modalities: Group and low intensity intervention trials had 
comparably large sample sizes, with an average sample size per trial of 128 and 129.5 women 
respectively, in contrast to the average trial sample size of 54 women for RCTs of 




As Table 2 indicates, participant characteristics were not reported uniformly. Of the available 
data, the majority of studies included women who were young (mean age= 53.08 years), less 
than two years post-diagnosis of MBC at study entry (pooled time since diagnosis= 1.96 
years), partnered/married (68.4% of included study participants), English speaking (86.7% of 
studies), and Caucasian (89.8% of included studies). While 62.2% of participants overall 
were tertiary educated, only 31.9% of participants were employed. While participant 
characteristics in general did not differ between treatment modalities, a notable exception was 
education level: based on the eight studies reporting education, only 47.3% of group 
participants were tertiary educated, compared to 58.5% and 80.9% of individual and low-
intensity participants, respectively. Group participants were nearly five years younger than 
those in individual therapy, and three years younger than low-intensity intervention 
participants, while women in individual therapy were more recently diagnosed than the other 
two modalities.  
Intervention characteristics 
As Table 2 summarises, group interventions had the highest participation-
burden/commitment, as measured by the maximum number of hours of treatment a 
participant might receive. Group interventions had an average intervention duration of 60 
hours (ranging from 16 to 78 hours). This was notably higher than in individually-delivered 
(6.83 hours), and low intensity (3.79 hours) interventions, and nearly double the pooled 
interventions’ average-duration of 32.6 hours.   
Only 10 trials [27, 32, 33, 38, 40-43, 45, 48] summarised uptake data, while all 15 trials 
reported on adherence. As the number of intervention-hours decreased, the uptake rate 
increased: uptake was highest at 71.9% amongst low-intensity interventions (range 69-89%) 
and lowest at 41.9% for group delivery formats (range 19-79%), with individually-
administered therapy falling in between (60.5%; range 60-61%). As Table 4 demonstrates, a 
similar pattern was observed for adherence, with the exception that individual therapy had 
lower adherence than group programs. 
Discussion 
Since 1980, only 15 trials (published across 23 articles) using rigorous randomised controlled 
designs, have examined psychotherapeutic interventions for MBC. Only one new study has 
been published in this area in the last five years and no studies of web-based interventions 
have been published. This was contrary to expectations, given that research and service 
provision for women with MBC has increasingly been recognised as a priority area [19], 
combined with the interest in web-based interventions for cancer [9-16].  
No evidence of a survival benefit was found in the present review; while this contrasts with 
the one-year survival benefit found in the earlier Cochrane Review [8], the present review 
examined overall survival, rather than separating 1-year versus 5-year survival rates, and was 
therefore consistent with the Cochrane Review finding of no survival-benefit at five years. 
This finding was unsurprising. given that only one additional RCT was identified which 
examined this relationship [44]. This study had a very small sample size (n=43), did not have 
survival as its primary aim, and was underpowered for such an analysis; furthermore, the 
final assessment period was only six months after study entry, therefore too short to examine 
survival advantage adequately. While the mechanism for increasing survival is plausible, 
given the postulated relationship between depression and reduced survival [4, 50]; findings 
indicating stress may lead to cancer progression [51];  that social support/marital status can 
have as powerful an impact on survival as chemotherapy [52]; and that depression reduces 
10 
 
adherence to medical treatments [53], to date none of the interventions trialled appear to have 
yielded large enough effects to impact on these mechanisms. A trial examining whether 
treating depression among those most vulnerable - such as socially isolated individuals - can 
improve survival would be beneficial. While promising, such a study would be difficult to 
power and conduct, given the large sample size and very long-term follow-up required.  
Consistent with earlier reviews, this review did obtain evidence to support the use of 
psychological therapies overall (pooling across delivery-modality) for distress, select coping 
domains (helplessness/hopelessness and restraint-coping), and pain. This positive impact on 
distress is particularly notable, given that for all included studies, except one [48], elevated 
distress was not an inclusion criteria, therefore floor effects may have been operating. For the 
remaining psychosocial outcomes, namely quality of life, fatigue, and sleep, the evidence was 
either insufficient, or too mixed to draw conclusions, indicating that further research on the 
use of psychological therapies to improve these outcomes in women with MBC is warranted. 
When summarising outcomes by treatment modality, this study indicates that the evidence-
base for psychological therapies has been largely generated by group therapy studies, which 
were the most intensive (i.e., weekly for up to a year).  Individual interventions did not meet 
criteria for a supported intervention for any outcome; however, as most outcomes were only 
investigated in single studies, further research in this area is required to clarify findings. Only 
tentative support was found for low-intensity interventions regarding one outcome, sleep; no 
support was found for fatigue and distress, and an unclear evidence-base was noted for pain. 
Therefore, at this stage both individual and low-intensity interventions have insufficient 
evidence to form conclusions regarding efficacy or to make recommendations for their use, 
and it remains premature to directly compare group interventions with other modalities of 
support.  While groups were most efficacious, the program efficacy must be balanced against 
cost-effectiveness considerations which have not been explicitly summarised. 
While it was outside the scope of the present review to comprehensively summarise 
outcomes by specific therapeutic frameworks, it was noted that seven of the eight positive 
studies for distress used either SEGT or CBT [31, 33, 37, 38, 40, 45, 48]. Whilst the study 
combining CBT with SEGT reported only one significant result, improved 
helplessness/hopelessness [32], it should be noted that this RCT used an active treatment 
(self-help CBT) as the comparator. While it is possible that this self-help (low-intensity) CBT 
comparator provided equivalent benefit to more intensive psychological treatments, this was 
not tested, as the trial was not a non-inferiority study; head-to-head trials comparing efficacy 
across treatment-modalities could be usefully examined in future research. While low-
intensity interventions did not have a sufficient evidence-base to recommend dissemination 
from the current review, this may be due to the fact that three of the four included low-
intensity RCTs did not test established therapeutic frameworks. Indeed, the only low-
intensity intervention testing an established framework (CBT) obtained more significant 
results than the other three low-intensity interventions that trialled other therapeutic 
frameworks [37].  
While group programs clearly had the strongest empirical base for their use, it is notable that 
no new group-based RCTs have emerged since the last Cochrane Review on this topic. A 
number of reasons likely exist for this, including reduced research funding, general debate 
over the efficacy and acceptability of psychological  interventions for cancer patients, and 
hence the value of further research on such interventions (e.g. [54, 55]). However, it is 
important to consider that the burden of participation and high cost/resource use are 
significant barriers to uptake of group interventions. Indeed, this study highlighted that 
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groups required the highest levels of commitment, with an average of 60 hours of 
participation, nearly 10 times the commitment required for individual therapy and 15 times 
greater than low-intensity interventions. Overall, as intervention duration increased, uptake 
and adherence decreased. Disparities between those who took up interventions and those who 
declined were also discernible from this review: across the included studies that reported 
demographic characteristics, there was a general pattern for young, married/partnered, 
Caucasian, English-speaking women to be over-represented.  Eligibility criteria for most 
studies also required women to live within close proximity of the Cancer Centre where the 
studies were being conducted (for face-to-face interventions), therefore reducing the 
likelihood of rural / regional women participating. Thus, given the high level of commitment 
required for group therapy, restrictions in uptake on rural/regional women, low adherence 
rates for individual therapies and higher adherence rates for low-intensity therapies found in 
this review, one way in which to address the need for accessible low-burden interventions 
may be to explore low-intensity interventions based on established therapeutic frameworks, 
such as SEGT, CBT or Acceptance and Commitment Therapy (ACT).  Moreover, given the 
success of web-based interventions as a specific example of low-intensity intervention in 
treating distress related to a range of chronic physical health conditions [17], online 
interventions based on therapeutic frameworks may be the most obvious choice in balancing 
the need for efficacy with uptake and adherence in interventions available to women with 
MBC. This could also offer the benefit of providing online social support, as many online 
programs incorporate forums and can be run in group formats.  
Methodological quality  
None of the studies met all quality criteria, suggesting need for improvements in the 
methodological quality of research design and reporting.  This does not imply that the studies 
were of poor quality; rather, that reporting was not transparent and many criteria could not be 
determined from the available information. It should be noted that over the 35-year timeframe 
that these studies were conducted, the reporting criteria required by journals have markedly 
changed, with methods developed to improve the quality of reporting of trials such as the 
CONSORT statement and checklist [56]. The substantial heterogeneity of research design, 
analytic strategy, comparator groups, methodological quality, sample sizes, and outcome 
measures utilised further increases the challenges arising when evaluating efficacy. For 
example, only seven of the 15 included RCTs specified a primary outcome; even when stated, 
these primary outcomes varied markedly across survival and psychosocial outcomes so it was 
not possible to summarise efficacy by primary outcomes.  Methods for improving the quality 
of design could therefore include standardising the range of outcome measures utilised, 
specifying and powering to a primary outcome, and using treatment-as-usual or appropriate 
placebo-controls rather than waitlist or active-treatment comparators. As prior reviews have 
noted, waitlist designs are problematic as control-participants anticipate future therapeutic 
input and are therefore less likely to seek constructive action compared to other control-group 
types [57]. While active-comparators are methodologically strong, they are generally only 
adopted in settings where strong evidence-based gold-standard treatments exist and non-
inferiority designs are appropriate. Given the overall paucity of psychological intervention 
trials in MBC, it is premature to be testing non-inferiority, and efforts should instead be 
directed to building the evidence-base for psychological treatments. Two of the included 
studies utilised an active comparator [32, 37]. Finally, ensuring that sample sizes are 
sufficient to meet power requirements for statistical analysis would greatly benefit this area, 
as only 40% of included RCTs were adequately powered.  
Limitations and future directions 
12 
 
The current review has several limitations. First, the effect sizes of outcomes were not 
summarised, as these data were not routinely or consistently reported across trials. Second, 
studies often included multiple follow-up assessment points, however these points differed 
immensely between studies, or assessments were aggregated into an average/composite 
follow-up score making it difficult to summarise outcomes by time-periods. While all 
available data was extracted, this review elected to summarise the overall impact on 
psychosocial domains (that is, whether the intervention led to a significant group difference at 
any of the assessments), rather than differentiating the short- versus long-term impact, or 
changes over time within outcomes. However, for many of the included studies, psychosocial 
effects were short-term / not sustained or required a lengthy course of psychological 
treatment to obtain effects (e.g., a full year of SEGT to obtain statistically significant group 
differences). Third, in addition to reporting requirements changing over the 35-year period 
over which included studies were conducted, the oncology landscape for treating metastatic 
breast cancer (including average survival time, side effects, and resulting quality of life) has 
also changed significantly, with the advent of new systemic treatments [2]. Therefore any 
conclusions made when comparing psychological interventions delivered across this broad 
time-frame should be made with caution. Likewise, the discipline of psycho-oncology – 
particularly our understanding of the mechanisms through which psychological interventions 
lead to change - has also matured over that time period. While SEGT and CBT remain the 
gold-standard treatments, more emphasis in recent times has been placed on the role of 
perseverative thinking (worry and rumination), attentional biases, and metacognitive 
processes as maintenance factors for psychological morbidity [58]. None of the included 
studies have examined interventions that specifically target these factors, such as the ‘third-
wave’ psychological intervention strategies (metacognitive or mindfulness-based therapies), 
despite a recent Breast Cancer Gap Analysis identifying this as a priority for research [59]. 
Given the promising evidence emerging for these new intervention types in non-metastatic 
populations [60] and in metastatic/advanced disease populations that are not breast-cancer 
specific [61-63], this is a useful avenue for future research. Finally, it should be noted that 
grey literature was excluded from this review, as there is a high discordance in the abstract-
to-publication rates and quality; grey literature often only reports preliminary results that are 
unrepresentative of final observations once all data is collected and analysed [64], with 
results changing in up to 42% of the abstract-to-publication comparisons [65]. Given this, 
only final fully-published (and data-extractable) peer-reviewed articles were eligible for 
inclusion. 
Summary 
In summary, this review confirms the paucity of research addressing the unmet psychological 
needs of women with MBC, and highlights the challenge of balancing efficacious treatments 
against accessibility, reduced burden, and increased acceptability. There is a lack of research 
evidence on efficacy of interventions in women of diverse ethnic background, socioeconomic 
status, and broader age-ranges. It is paramount to ensure interventions reach, and meet the 
needs of, a broad range of women with MBC, while simultaneously providing evidence-
based benefits. While psychological therapies had consistent support for their use in 
improving distress, aspects of coping, and pain, when separated by treatment modality this 
evidence is only applicable to group-delivered programs at this stage; the evidence-base is 
insufficient for individual therapies and low-intensity interventions. More research is 
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Group Individual Low Intensity RCTs 
Pooled 
  Positive Negative Conclusion Positive Negative Conclusion Positive Negative Conclusion Conclusion 
Survival 6 1 5 No support 0 0 n/a 0 0 n/a No support 
Distress 13 6 1 Supported 1 1 Unclear 1 3 No support Supported 
Coping 5 4a 0 Supported 0 1 Unclear 0 0 n/a Supported 
Quality of Life 6 1b 2 Unclear 0 3 No support 0 0 n/a No support 
Pain 5 3 0 Supported 1 0 Unclear 0 1 Unclear Supported 
Fatigue 5 1 1 Unclear 0 1 Unclear 0 2 No support No support 
Sleep 4 0 0 n/a 0 1 Unclear 2c 1 Support Unclear 
aSupported for helplessness, restraint and ‘maladaptive-coping’ subscale; not for denial or defensive-repressive 
bOnly for social functioning 




Table 2. Trial context factors and intervention duration, by treatment delivery modality 
Outcomes Group (n=7) Individual (n=4) Low Intensity (n=4) Pooled (n=15) 
Trial Characteristics     
Sample size (SS) 




N=217 (range: 24-205) 
M=54.3 
N=518 (range: 47-308) 
M=129.5 
N=1638 (range: 24-308) 
M: 109 
Participant Characteristics         
Age, years (n RCTs) 51.60 (N=6) 56.29 (N=3) 54.73 (N=4) 53.08 (N=13) 
Years since MBC diagnosis (n 
RCTs) 
2.50 (N=4) 0.75 (N=3) 2.64 (N=3) 1.96 (N=10) 
English language (n RCTs) 100% (N=7) 50% (N=4) 100% (N=4) 86.7% (N=13) 
Caucasian ethnicity (n RCTs) 85.5% (N=2) 98.0% (N=2) 86.0% (N=4) 89.8 (N=8) 
Married (n RCTs) 67.5% (N=6) 66.3% (N=3) 71.3% (N=3) 68.4% (N=12) 
Tertiary educated (n RCTs) 47.3% (N=2) 58.5% (N=3) 80.9% (N=3) 62.2% (N=8) 
Employed (n RCTs) 36% (N=2) 31.3% (N=2) 28.5% (N=2) 31.9% (N=6) 
Intervention characteristics     
Uptake (n RCTs; range) 41.9% (N=6; 19-79%) 60.5% (N=2; 60-61%) 79.1% (N=2; 69-89%) 53.02 (N=10; 19-89%) 
Adherence (n RCTs; range) 66.1% (N=7; 43-82%) 62.6% (N=4; 40-100%) 85.9% (N=4; 80-96%%) 69.3% (N=15, 40-100%) 
Intervention average duration (range) 60 hours (16-78) 6.83 hours (2-16.5)a 3.79 hours (1.33-6.5) 32.6 hours (1.33-78) 
Notes: a One study did not report intervention duration, beyond stating sessions were unlimited (range not reported). Therefore calculation based on N=3 trials 
with available data. Attrition calculated from treatment- or post-treatment attrition rates, where reported, it does not include follow-up assessment attrition. 
